NewcelX Welcomes Diabetes Expert Dr. Julien Boisdron to Scientific Advisory Board NewcelX Ltd. has announced the appointment of Dr. Julien Boisdron to its Scientific Advisory Board, enhancing its focus on diabetes therapies.

NewcelX Welcomes Diabetes Expert Dr. Julien Boisdron to Scientific Advisory Board #Switzerland #Zurich #IsletRx #NewCelX #Dr._Julien_Boisdron

NLS Pharmaceutics and Kadimastem Achieve Patent Milestone for Diabetes Cure in Hong Kong NLS Pharmaceutics and Kadimastem's recent patent grant in Hong Kong enhances their IsletRx technology, aiming to revolutionize diabetes treatment.

NLS Pharmaceutics and Kadimastem Achieve Patent Milestone for Diabetes Cure in Hong Kong #Switzerland #NLS_Pharmaceutics #Zurich #Kadimastem #IsletRx